Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Nadine, Houédé"'
Autor:
Alexandra Fauvre, Margot Machu, Audrey Merienne, Nadia Vie, Thomas Bessede, Mathilde Robin, Veronique Garambois, Clara Taffoni, Nadine Laguette, Nadine Gervois‐Segain, Anne Jarry, Nathalie Labarriere, Yves Allory, Christel Larbouret, Laurent Gros, Diego Tosi, David B. Solit, Philippe Pourquier, Nadine Houédé, Celine Gongora
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 9, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/909d3363b27643e8a03718ec78c8c871
Autor:
Nadine Houédé, Xavier Rébillard, Sophie Bouvet, Sarah Kabani, Pascale Fabbro-Peray, Brigitte Trétarre, Florence Ménégaux
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Prostate cancer patients are known to suffer from poor sexual and urinary long-term side-effects following treatment, potentially impacting quality of life. The purpose of our study was to compare health-related quality of life at
Externí odkaz:
https://doaj.org/article/6b0f1933cc7f4adabb05156f43ce973d
Autor:
Marina Pulido, Guilhem Roubaud, Anne-Laure Cazeau, Hakim Mahammedi, Lionel Vedrine, Florence Joly, Loic Mourey, Christian Pfister, Alejandro Goberna, Barbara Lortal, Carine Bellera, Philippe Pourquier, Nadine Houédé
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Bladder cancer is the 7th cause of death from cancer in men and 10th in women. Metastatic patients have a poor prognosis with a median overall survival of 14 months. Until recently, vinflunine was the only second-line chemotherapy
Externí odkaz:
https://doaj.org/article/2fac6bb4f1f54d83a46c301be59e7f10
Publikováno v:
The Arab Journal of Interventional Radiology, Vol 1, Iss 02, Pp 64-67 (2017)
Purpose: To evaluate the morbidity and efficacy of percutaneous radiofrequency ablation (RFA) performed before surgical resection for multiple residual lung metastases of germ cell tumors with negative tumor markers. Materials and Methods: This Revie
Externí odkaz:
https://doaj.org/article/c7ecdf54388042a28b7bff7d45307fb5
Autor:
Nadine Houédé, Cécile Flahault, Marine Gross-Goupil, Solenn Le Clanche, Yann Le Goff, Frédérick Merlier, Géraldine Pignot, Bertrand Pourroy, Constance Thibault, Evanguelos Xylinas, Marie-Noelle Solbes, Gwenael Dénéchère, Morgan Roupret
Publikováno v:
Bulletin du Cancer. 109:925-937
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2b47fb7baffbe2911b1510d80eaf72
https://doi.org/10.1016/j.bulcan.2022.04.010
https://doi.org/10.1016/j.bulcan.2022.04.010
Publikováno v:
European Urology Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::feb27a0b71684903b32ded1e8f1ec3d0
https://doi.org/10.1016/j.euo.2023.05.001
https://doi.org/10.1016/j.euo.2023.05.001
Publikováno v:
Bulletin du Cancer. 109:623-629
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20d3ba8ed9cd36cf5df3b04b44b81bbe
https://doi.org/10.1016/j.bulcan.2021.11.014
https://doi.org/10.1016/j.bulcan.2021.11.014
Autor:
Ana Cavillon, Damien Pouessel, Nadine Houédé, Fanny Mathevet, Jean Yves Dauxois, Christine Chevreau, Stéphane Culine, Jean-Pierre Delord, Raphael Porcher, Thomas Filleron
Publikováno v:
European Urology
European Urology, 2023, pp.1-8. ⟨10.1016/j.eururo.2023.02.011⟩
European Urology, 2023, pp.1-8. ⟨10.1016/j.eururo.2023.02.011⟩
International audience; BackgroundThe Keynote-045 trial illustrates that the long-term benefit (LTB) of treatment does not always translate to improved progression-free survival (PFS). Milestone survival and flexible parametric survival model with cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e4689d6c7882a50829a075a9c89a0e
https://hal-cnam.archives-ouvertes.fr/hal-04086906
https://hal-cnam.archives-ouvertes.fr/hal-04086906
Autor:
Nadine Houédé, Philippe Pourquier
Publikováno v:
Bulletin du Cancer. 109:881-883
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::888886c149622cffd3747dff2b659f73
https://doi.org/10.1016/j.bulcan.2022.06.007
https://doi.org/10.1016/j.bulcan.2022.06.007
Autor:
Nadine, Houédé, Philippe, Pourquier
Publikováno v:
Bulletin du cancer. 109(9)
Castration resistant prostate cancers are highly heterogenous at the molecular level. With the use of new generation sequencing technologies, a series of alterations were identified, opening the way for potential alternative treatments that could be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b402e1d2349e6ec2767065afbac29ade
https://pubmed.ncbi.nlm.nih.gov/35871861
https://pubmed.ncbi.nlm.nih.gov/35871861